LL37

CAMP
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCAMP, CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26, LL37, cathelicidin antimicrobial peptide
External IDsOMIM: 600474 MGI: 108443 HomoloGene: 110678 GeneCards: CAMP
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

820

12796

Ensembl

ENSG00000164047

ENSMUSG00000038357

UniProt

P49913

P51437

RefSeq (mRNA)

NM_004345

NM_009921

RefSeq (protein)

NP_004336

NP_034051

Location (UCSC)Chr 3: 48.22 – 48.23 MbChr 9: 109.85 – 109.85 Mb
PubMed search[1][2]
Wikidata
View/Edit HumanView/Edit Mouse

LL-37 (or CAP-18 for cathelicidin antimicrobial peptide, 18 kDa) is a gene encoding for the only member of the human cathelicidin family. Cathelicidin-related antimicrobial peptides are a family of polypeptides found in lysosomes of macrophages and polymorphonuclear leukocytes (PMNs), and keratinocytes.[3] Cathelicidins serve a critical role in mammalian innate immune defense against invasive bacterial infection.[4]

Clinical significance

Patients with rosacea have elevated levels of cathelicidin. Cathelicidin is cleaved into the antimicrobial peptide LL-37 by both kallikrein 5 and kallikrein 7 serine proteases. Excessive production of LL-37 is suspected to be a contributing cause in all subtypes of Rosacea.[5]

Higher plasma levels of LL-37, which are up-regulated by vitamin D, appear to significantly reduce the risk of death from infection in dialysis patients. Patients with a high level of LL-37 were 3.7 times more likely to survive kidney dialysis for a year without a fatal infection.[6] Vitamin D up-regulates genetic expression of cathelicidin, which exhibits broad-spectrum microbicidal activity against bacteria, fungi, and viruses.[7][8]

See also

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. "Entrez Gene: CAMP cathelicidin antimicrobial peptide".
  4. Zanetti M (Jan 2004). "Cathelicidins, multifunctional peptides of the innate immunity". Journal of Leukocyte Biology. 75 (1): 39–48. PMID 12960280. doi:10.1189/jlb.0403147.
  5. Reinholz M, Ruzicka T, Schauber J (2012). "Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease". Ann Dermatol. 24 (2): 126–35. PMC 3346901Freely accessible. PMID 22577261. doi:10.5021/ad.2012.24.2.126.
  6. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA, Koeffler HP, Thadhani R (Feb 2009). "Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis". Clinical Infectious Diseases. 48 (4): 418–24. PMID 19133797. doi:10.1086/596314.
  7. Zasloff M (Jan 2002). "Antimicrobial peptides of multicellular organisms". Nature. 415 (6870): 389–95. PMID 11807545. doi:10.1038/415389a.
  8. Kamen DL, Tangpricha V (May 2010). "Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity". Journal of Molecular Medicine (Berlin, Germany). 88 (5): 441–50. PMC 2861286Freely accessible. PMID 20119827. doi:10.1007/s00109-010-0590-9.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.